Medicover AB (MCOVb)

Currency in SEK
209.5000
+0.5000(+0.24%)
Closed·
MCOVb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
208.5000212.0000
52 wk Range
183.4000295.0000
Key Statistics
Prev. Close
209.5
Open
210
Day's Range
208.5-212
52 wk Range
183.4-295
Volume
65.36K
Average Volume (3m)
81.25K
1-Year Change
1.2077%
Book Value / Share
38.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MCOVb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
257.2575
Upside
+22.80%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Medicover AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Medicover AB Company Profile

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Employees
49000
Market
Sweden

Compare MCOVb to Peers and Sector

Metrics to compare
MCOVb
Peers
Sector
Relationship
P/E Ratio
38.6x19.5x−0.5x
PEG Ratio
0.110.010.00
Price/Book
5.6x2.1x2.6x
Price / LTM Sales
1.3x0.8x3.3x
Upside (Analyst Target)
18.3%19.9%47.0%
Fair Value Upside
Unlock18.0%5.7%Unlock

Analyst Ratings

3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 257.2575
(+22.80% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Deutsche Bank
Hold265.00+26.49%215.00MaintainSep 29, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.51%
Dividend Yield
0.10%
Industry Median 1.49%
Annualised payout
0.20
Paid annually
5-Years Growth
+23.36%
Growth Streak

Earnings

Latest Release
Feb 10, 2026
EPS / Forecast
0.13 / 0.1307
Revenue / Forecast
611.70M / 623.58M
EPS Revisions
Last 90 days

MCOVb Income Statement

FAQ

What Is the Medicover (MCOVb) Stock Price Today?

The Medicover stock price today is 209,5000

What Stock Exchange Does Medicover Trade On?

Medicover is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Medicover?

The stock symbol for Medicover is "MCOVb."

Does Medicover Pay Dividends? What’s The Current Dividend Yield?

The Medicover dividend yield is 0.1%.

What Is the Medicover Market Cap?

As of today, Medicover market cap is 31,6300B.

What Is Medicover's Earnings Per Share (TTM)?

The Medicover EPS (TTM) is 0,5130.

When Is the Next Medicover Earnings Date?

Medicover will release its next earnings report on Apr 29, 2026.

From a Technical Analysis Perspective, Is MCOVb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Medicover Stock Split?

Medicover has split 0 times.

How Many Employees Does Medicover Have?

Medicover has 49000 employees.

What is the current trading status of Medicover (MCOVb)?

As of Feb 17, 2026, Medicover (MCOVb) is trading at a price of 209,5000, with a previous close of 209,5000. The stock has fluctuated within a day range of 208,5000 to 212,0000, while its 52-week range spans from 183,4000 to 295,0000.

What Is Medicover (MCOVb) Price Target According to Analysts?

The average 12-month price target for Medicover is SEK257,2575, with a high estimate of SEK300.78306878 and a low estimate of SEK220.44444444. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +22,80% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.